80 jobs found in bridgewater

Amarin Corporation plc (“Amarin”) is a rapidly growing pharmaceutical company developing and selling therapeutics to improve cardiovascular health. Amarin, a publicly traded company (NASDAQ: AMRN) with approximately 900 employees, is headquartered in Dublin, Ireland and has its US operations (Amarin Pharma Inc.) based in Central New Jersey. Amarin has successfully developed, registered and launched VASCEPA® in the U.S. market with a network of third-party companies aligned with Amarin to advance commercialization of VASCEPA® globally. In the U.S., VASCEPA® was launched in 2013 for its initial indication of as a treatment of Very High Triglycerides (i.e. patients with TG levels ≥ 500mg/dL). In November 2018, unprecedented clinical results were announced from a landmark global cardiovascular outcomes study in which VASCEPA®demonstrated a significantly lower risk of cardiovascular events beyond the current standard of care for cholesterol management....

We Create Medicines and Solutions That Make a Real Difference But it’s more than what we discover—it’s how we get there. WHO WE ARE Meeting the needs of our times AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.

We Create Medicines and Solutions That Make a Real Difference But it’s more than what we discover—it’s how we get there. WHO WE ARE Meeting the needs of our times AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.

We Create Medicines and Solutions That Make a Real Difference But it’s more than what we discover—it’s how we get there. WHO WE ARE Meeting the needs of our times AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.

We Create Medicines and Solutions That Make a Real Difference But it’s more than what we discover—it’s how we get there. WHO WE ARE Meeting the needs of our times AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.

We Create Medicines and Solutions That Make a Real Difference But it’s more than what we discover—it’s how we get there. WHO WE ARE Meeting the needs of our times AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.

We Create Medicines and Solutions That Make a Real Difference But it’s more than what we discover—it’s how we get there. WHO WE ARE Meeting the needs of our times AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.

We Create Medicines and Solutions That Make a Real Difference But it’s more than what we discover—it’s how we get there. WHO WE ARE Meeting the needs of our times AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.

We Create Medicines and Solutions That Make a Real Difference But it’s more than what we discover—it’s how we get there. WHO WE ARE Meeting the needs of our times AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.

We Create Medicines and Solutions That Make a Real Difference But it’s more than what we discover—it’s how we get there. WHO WE ARE Meeting the needs of our times AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.

We Create Medicines and Solutions That Make a Real Difference But it’s more than what we discover—it’s how we get there. WHO WE ARE Meeting the needs of our times AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. 

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. 

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. 

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. 

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. 

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. 

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. 

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. 

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.